Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 2/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.51 |
| ▸ | CPB2 | Q96IY4 | 6/20 | 0.50 |
| ▸ | CPB1 | P15086 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | CPN1 | P15169 | 1/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20850639 | 0.98 | TBXAS1 (0.54) | HRH1HTR2ATBXAS1CPB2CPB1 | |
| SCHEMBL3781893 | 0.94 | HRH1 (0.59) | HRH1HTR2ATBXAS1CPB2CPB1 | |
| SCHEMBL14360139 | 0.88 | TBXAS1 (0.60) | TBXAS1CPB2CYP2C19EPHX1CPN1 | |
| SCHEMBL1613696 | 0.86 | HRH1 (0.56) | HRH1HTR2ATBXAS1CPB2CYP2C19 | |
| Ammonia Solution, Strong SCHEMBL28556745 | 0.86 | TBXAS1 (0.59) | TBXAS1CPB2CYP2C19EPHX1CPN1 | |
| Ammonia Solution, Strong SCHEMBL28562956 | 0.86 | TBXAS1 (0.59) | TBXAS1CPB2CYP2C19EPHX1CPN1 | |
| Hydrochloric Acid SCHEMBL1093394 | 0.85 | HRH1 (0.54) | HRH1HTR2ATBXAS1CPB2CYP2C19 | |
| SCHEMBL27843751 | 0.85 | HRH1 (0.54) | HRH1HTR2ATBXAS1CPB2CYP2C19 | |
| SCHEMBL6014424 | 0.84 | CPB2 (0.49) | TBXAS1CPB2CPB1GSRRNPEP | |
| SCHEMBL7379796 | 0.83 | MMP2 (0.49) | HRH1HTR2ATBXAS1CPB2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106191147-B | Preparation method of chiral β -amino acid | 凯莱英医药集团（天津）股份有限公司 | 2020-03-27 | — | — | CN | disclosed |
| US-20070287699-A1 | ANTIVIRAL AGENTS | VIROBAY, INC. (US) | 2007-12-13 | — | — | US | disclosed |
| WO-2007130499-A2 | ANTIVIRAL AGENTS | VIROBAY, INC. (US) | 2007-11-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070287699-A1 | ANTIVIRAL AGENTS | EIF2AK2, MAVS, ZC3HAV1 | HRH1 3052/4885HTR2A 4400/4885TBXAS1 864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.